Granahan Investment Management - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 221 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$7,633,000
-51.3%
469,430
-58.5%
0.19%
-41.3%
Q4 2021$15,659,000
+25.6%
1,130,578
+30.3%
0.32%
+35.9%
Q3 2021$12,472,000
+73.8%
867,920
+91.2%
0.24%
+76.9%
Q2 2021$7,178,000
+64.2%
453,995
+5.6%
0.13%
+44.1%
Q1 2021$4,372,000429,9020.09%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RP Management, LLC 3,846,154$27,230,77026.28%
Prosight Management, LP 2,408,135$17,049,5965.40%
Kynam Capital Management, LP 3,133,193$22,183,0063.63%
Saturn V Capital Management LP 982,458$6,955,8032.91%
AlphaCentric Advisors LLC 649,000$4,594,9202.61%
TANG CAPITAL MANAGEMENT LLC 1,800,000$12,744,0001.80%
SILVERARC CAPITAL MANAGEMENT, LLC 791,671$5,605,0311.70%
Eversept Partners, LP 2,479,103$17,552,0491.48%
DAFNA Capital Management LLC 652,000$4,616,1601.44%
Avoro Capital Advisors LLC 11,550,000$81,774,0001.28%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders